These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 23134110)

  • 1. BclI polymorphism of the glucocorticoid receptor gene is associated with increased bone resorption in patients on glucocorticoid replacement therapy.
    Koetz KR; van Rossum EF; Ventz M; Diederich S; Quinkler M
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):831-7. PubMed ID: 23134110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.
    Koetz KR; Ventz M; Diederich S; Quinkler M
    J Clin Endocrinol Metab; 2012 Jan; 97(1):85-92. PubMed ID: 21994966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BclI polymorphism of the glucocorticoid receptor gene is associated with decreased bone mineral density in patients with endogenous hypercortisolism.
    Szappanos A; Patócs A; Tõke J; Boyle B; Sereg M; Majnik J; Borgulya G; Varga I; Likó I; Rácz K; Tóth M
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):636-43. PubMed ID: 19207316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BClI polymorphism of the glucocorticoid receptor gene is associated with increased obesity, impaired glucose metabolism and dyslipidaemia in patients with Addison's disease.
    Giordano R; Marzotti S; Berardelli R; Karamouzis I; Brozzetti A; D'Angelo V; Mengozzi G; Mandrile G; Giachino D; Migliaretti G; Bini V; Falorni A; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2012 Dec; 77(6):863-70. PubMed ID: 22587831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia.
    Guo CY; Weetman AP; Eastell R
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):535-41. PubMed ID: 8977749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral density and bone turnover in Romanian children and young adults with classical 21-hydroxylase deficiency are influenced by glucocorticoid replacement therapy.
    Zimmermann A; Sido PG; Schulze E; Al Khzouz C; Lazea C; Coldea C; Weber MM
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):477-84. PubMed ID: 19170706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in daily hydrocortisone dose improves bone health in primary adrenal insufficiency.
    Schulz J; Frey KR; Cooper MS; Zopf K; Ventz M; Diederich S; Quinkler M
    Eur J Endocrinol; 2016 Apr; 174(4):531-8. PubMed ID: 26811406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency.
    Sciannamblo M; Russo G; Cuccato D; Chiumello G; Mora S
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4453-8. PubMed ID: 16926248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone.
    Løvås K; Gjesdal CG; Christensen M; Wolff AB; Almås B; Svartberg J; Fougner KJ; Syversen U; Bollerslev J; Falch JA; Hunt PJ; Chatterjee VK; Husebye ES
    Eur J Endocrinol; 2009 Jun; 160(6):993-1002. PubMed ID: 19282465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid receptor polymorphisms and post-traumatic stress disorder.
    Bachmann AW; Sedgley TL; Jackson RV; Gibson JN; Young RM; Torpy DJ
    Psychoneuroendocrinology; 2005 Apr; 30(3):297-306. PubMed ID: 15511603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional glucocorticoid receptor gene variants do not underlie the high variability of 17-hydroxyprogesterone screening values in healthy newborns.
    Schreiner F; Tozakidou M; Maslak R; Holtkamp U; Peter M; Gohlke B; Woelfle J
    Eur J Endocrinol; 2009 Apr; 160(4):667-73. PubMed ID: 19174530
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Zopf K; Frey KR; Kienitz T; Ventz M; Bauer B; Quinkler M
    Endocr Connect; 2017 Nov; 6(8):685-691. PubMed ID: 28954735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
    Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia.
    Falhammar H; Filipsson Nyström H; Wedell A; Brismar K; Thorén M
    Eur J Endocrinol; 2013 Mar; 168(3):331-41. PubMed ID: 23211577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of glucocorticoid receptor polymorphisms in relation to metabolic parameters in Addison's disease.
    Ross IL; Levitt NS; Van der Merwe L; Schatz DA; Johannsson G; Dandara C; Pillay TS; Blom DJ
    Eur J Endocrinol; 2013 Mar; 168(3):403-12. PubMed ID: 23239757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of glucocorticoid replacement therapy on bone mineral density in children with congenital adrenal hyperplasia.
    Cetinkaya S; Kara C
    J Pediatr Endocrinol Metab; 2011; 24(5-6):265-9. PubMed ID: 21823521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid replacement therapy: are patients over treated and does it matter?
    Peacey SR; Guo CY; Robinson AM; Price A; Giles MA; Eastell R; Weetman AP
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):255-61. PubMed ID: 9156031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia.
    Girgis R; Winter JS
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3926-9. PubMed ID: 9398689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mineral density and body composition in congenital adrenal hyperplasia.
    Cameron FJ; Kaymakci B; Byrt EA; Ebeling PR; Warne GL; Wark JD
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2238-43. PubMed ID: 7608286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum osteoprotegerin in patients with primary adrenal insufficiency receiving conventional hydrocortisone substitution.
    Fichna M; Zurawek M; Fichna P; Gryczynska M; Nowak J; Ruchala M
    J Physiol Pharmacol; 2012 Dec; 63(6):677-82. PubMed ID: 23388484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.